Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2023		74,661,479
Beginning balance at Dec. 31, 2023	$ 3,377,885	$ 747	$ 1,824,434	$ 1,552,653	$ 51
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	95,819			95,819
Other comprehensive income (loss)	(47)				(47)
Shares issued under stock-based compensation programs, net (in shares)		386,523
Shares issued under stock-based compensation programs, net	(25,626)	$ 3	(25,629)
Cash dividends declared	(41,276)			(41,276)
Stock-based compensation expense	2,632		2,632
Forfeiture of restricted stock (in shares)		(301)
Ending balance (in shares) at Mar. 31, 2024		75,047,701
Ending balance at Mar. 31, 2024	3,409,387	$ 750	1,801,437	1,607,196	4
Beginning balance (in shares) at Dec. 31, 2023		74,661,479
Beginning balance at Dec. 31, 2023	3,377,885	$ 747	1,824,434	1,552,653	51
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	120,953
Other comprehensive income (loss)	(27)
Ending balance (in shares) at Jun. 30, 2024		100
Ending balance at Jun. 30, 2024	2,830,088	$ 0	1,197,734	1,632,330	24
Beginning balance (in shares) at Mar. 31, 2024		75,047,701
Beginning balance at Mar. 31, 2024	3,409,387	$ 750	1,801,437	1,607,196	4
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	25,134			25,134
Other comprehensive income (loss)	20				20
Shares issued under stock-based compensation programs, net (in shares)		1,653
Shares issued under stock-based compensation programs, net	28		28
Stock-based compensation expense	173		173
Effect of Merger transaction (in shares)		(75,049,254)
Effect of Merger transaction	(604,654)	$ (750)	(603,904)
Ending balance (in shares) at Jun. 30, 2024		100
Ending balance at Jun. 30, 2024	$ 2,830,088	$ 0	1,197,734	1,632,330	$ 24
Beginning balance (in shares) at Dec. 31, 2024	100	100
Beginning balance at Dec. 31, 2024	$ 2,949,741	$ 0	1,197,734	1,752,007
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	40,082			40,082
Cash dividends declared	(86,836)			(86,836)
Ending balance (in shares) at Mar. 31, 2025		100
Ending balance at Mar. 31, 2025	$ 2,989,823	$ 0	1,197,734	1,792,089
Beginning balance (in shares) at Dec. 31, 2024	100	100
Beginning balance at Dec. 31, 2024	$ 2,949,741	$ 0	1,197,734	1,752,007
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	65,737
Other comprehensive income (loss)	$ 0
Ending balance (in shares) at Jun. 30, 2025	100	100
Ending balance at Jun. 30, 2025	$ 2,928,642	$ 0	1,197,734	1,730,908
Beginning balance (in shares) at Mar. 31, 2025		100
Beginning balance at Mar. 31, 2025	2,989,823	$ 0	1,197,734	1,792,089
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	25,655			25,655
Other comprehensive income (loss)	$ 0
Ending balance (in shares) at Jun. 30, 2025	100	100
Ending balance at Jun. 30, 2025	$ 2,928,642	$ 0	$ 1,197,734	$ 1,730,908

M.D.C. HOLDINGS, INC. 10-Q